on 10 Nov 2023
Last Applicant/ Owned by
VERTEX PHARMACEUTICALS INCORPORATED
50 Northern AvenueBoston MA 02210
US
Serial Number
2177876 filed on 3rd Mar 2022
Registration Number
TMA1209016 registered on 10th Nov 2023
Registration expiry Date
3rd Mar 2032Correspondent Address
PERLEY-ROBERTSON, HILL & MCDOUGALL LLP
1400 - 340 ALBERT STREETOTTAWA
ONTARIO
CA
K1R0A5
Trademark usage description
pharmaceutical preparations for the treatment of cystic fibrosis.11
2177876
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 27 on 28th Jul 2023 | Approval Notice Sent |
Submitted for opposition 26 on 28th Jul 2023 | Approved |
Submitted for opposition 22 on 24th Jul 2023 | Search Recorded |
Submitted for opposition 256 on 7th Feb 2023 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 20th Apr 2022 | Agent Changed |
Submitted for opposition 257 on 7th Apr 2022 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 6th Apr 2022 | Created |
Submitted for opposition 31 on 6th Apr 2022 | Formalized |
Submitted for opposition 30 on 3rd Mar 2022 | Filed |
Submitted for opposition 228 on 3rd Mar 2022 | International Registration |